NCT05844735View on ClinicalTrials.gov

A Randomized Placebo- and Active Comparator-controlled Study to Evaluate the Photosafety of SAR441566

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 22, 2023

Primary Completion Date

October 15, 2023

Study Completion Date

October 23, 2023

Conditions
Rheumatoid Arthritis
Interventions
DRUG

SAR441566

Tablet

DRUG

Placebo

Tablet

DRUG

Ciprofloxacin

Tablet

Trial Locations (1)

07410

TKL Research, Inc. Site Number : 8400001, Fair Lawn

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT05844735 - A Randomized Placebo- and Active Comparator-controlled Study to Evaluate the Photosafety of SAR441566 | Biotech Hunter | Biotech Hunter